Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 18, 2017; 9(8): 427-435
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.427
Table 2 Comparison of survival according to age, body mass index and hepatitis B virus status in a Eurotransplant control cohort (n = 2973)1
Patients who survived n (%)Patients who died n (%)P-value (χ2 test)
Age below 53 yr (n = 1809)1156 (64)653 (36)
Age above 53 yr (n = 1145)520 (45)625 (55)< 0.001
BMI below 24 kg/m2 (n = 1454)880 (61)574 (39)
BMI above 24 kg/m2 (n = 1493)796 (53)697 (47)< 0.001
Hepatitis B as underlying disease (n = 255)170 (67)85 (33)
Non-hepatitis B patients (n = 1705)946 (55)759 (45)< 0.001